Combination of hyaluronic acid and macrogol and pharmaceutical compositions containing it
AssigneeApharm S.R.L.
InventorAngelo Pizzoni
Life of this patent
Estimating the term…
Abstract
The invention relates to a new combination of hyaluronic acid and macrogol, pharmaceutical compositions containing said combination and the use of the combination and compositions as laxatives.
Claims14
A combination consisting of macrogol having molecular weight of between 3,000 and 5,000 Da and hyaluronic acid with an average molecular weight of between 50,000 and 300,000 Da or a salt thereof, wherein the macrogol and the sodium hyaluronate are in weight ratios from 40/1 to 10/1 (w/w/), respectively.
An oral pharmaceutical composition comprising pharmaceutically acceptable excipients and/or carriers, macrogol having molecular weight of between 3,000 and 5,000 Da and hyaluronic acid with an average molecular weight of between 50,000 and 300,000 Da or a salt thereof, wherein the macrogol and the sodium hyaluronate are in weight ratios from 40/1 to 10/1 (w/w/), respectively.
A method for treatment of constipation or colon cleansing comprising administering to a person in need thereof
- a combination consisting of macrogol having molecular weight of between 3,000 and 5,000 Da, hyaluronic acid with an average molecular weight of between 50,000 and 300,000 Da, or a salt thereof, and water;
- or
- an oral pharmaceutical composition comprising pharmaceutically acceptable excipients and/or carriers, macrogol having molecular weight of between 3,000 and 5,000 Da, hyaluronic acid with an average molecular weight of between 50,000 and 300,000 Da or a salt thereof, and water.
Dependencies are inferred from the claim text.